DrugPatentWatch Database Preview
Kvk Tech Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for KVK TECH, and what generic alternatives to KVK TECH drugs are available?
KVK TECH has thirteen approved drugs.
There are five US patents protecting KVK TECH drugs.
There are thirty-four patent family members on KVK TECH drugs in nineteen countries and forty-four supplementary protection certificates in seven countries.
Summary for Kvk Tech
| International Patents: | 34 |
| US Patents: | 5 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 13 |
Drugs and US Patents for Kvk Tech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kvk Tech | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 091042-001 | Aug 31, 2010 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Kvk Tech | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 078048-001 | Feb 28, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Kvk Tech | KALEXATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 040905-001 | Mar 30, 2009 | AA | RX | No | Yes | Start Trial | Start Trial | ||||
| Kvk Tech Inc | APADAZ | acetaminophen; benzhydrocodone hydrochloride | TABLET;ORAL | 208653-002 | Jan 4, 2019 | RX | Yes | No | 9,132,125 | Start Trial | Y | Y | Start Trial | ||
| Kvk Tech | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | TABLET;ORAL | 078962-002 | Jun 27, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Kvk Tech | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 040875-001 | Mar 21, 2008 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Kvk Tech | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 040876-001 | Mar 31, 2008 | AA | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kvk Tech Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3560336 | Start Trial |
| Cuba | 20110246 | Start Trial |
| China | 102480959 | Start Trial |
| Japan | 5442862 | Start Trial |
| Costa Rica | 20110688 | Start Trial |
| Israel | 217096 | Start Trial |
| Colombia | 6480991 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kvk Tech Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2203431 | CA 2015 00014 | Denmark | Start Trial | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115 |
| 0186405 | SPC/GB00/021 | United Kingdom | Start Trial | PRODUCT NAME: (1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE)BIS(PHOSPHONIC ACID) "RESIDRONATE" AND SALTS THEREOF, ESPECIALLY THE SODIUM SALT; REGISTERED: SE 15296 19991007; SE 15297 19991007; UK PL 00364/0070 20000316 |
| 0290047 | SPC/GB97/078 | United Kingdom | Start Trial | PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522 |
| 1259550 | 08C0052 | France | Start Trial | PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725 |
| 0268956 | 1999C0030 | Belgium | Start Trial | PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508 |
| 0788511 | SPC/GB08/036 | United Kingdom | Start Trial | PRODUCT NAME: MICAFUNGIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN PARTICULAR MICAFUNGIN SODIUM; REGISTERED: UK EU/1/08/448/001 20080425; UK EU/1/08/448/002 20080425 |
| 1912999 | 14C0076 | France | Start Trial | PRODUCT NAME: SIMEPREVIR OU L'UN DE SES SELS, INCLUANT LE SEL DE SODIUM DE SIMEPREVIR; REGISTRATION NO/DATE: EU/1/14/924 20140516 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
